233 related articles for article (PubMed ID: 23504322)
21. Transforming growth factor-β1 (TGF-β1) regulates cell junction restructuring via Smad-mediated repression and clathrin-mediated endocytosis of nectin-like molecule 2 (Necl-2).
Gao Y; Lui WY
PLoS One; 2013; 8(5):e64316. PubMed ID: 23741316
[TBL] [Abstract][Full Text] [Related]
22. Functional interaction between mouse erbB3 and wild-type rat c-neu in transgenic mouse mammary tumor cells.
Kim A; Liu B; Ordonez-Ercan D; Alvarez KM; Jones LD; McKimmey C; Edgerton SM; Yang X; Thor AD
Breast Cancer Res; 2005; 7(5):R708-18. PubMed ID: 16168116
[TBL] [Abstract][Full Text] [Related]
23. Nectin-like molecule-1/TSLL1/SynCAM3: a neural tissue-specific immunoglobulin-like cell-cell adhesion molecule localizing at non-junctional contact sites of presynaptic nerve terminals, axons and glia cell processes.
Kakunaga S; Ikeda W; Itoh S; Deguchi-Tawarada M; Ohtsuka T; Mizoguchi A; Takai Y
J Cell Sci; 2005 Mar; 118(Pt 6):1267-77. PubMed ID: 15741237
[TBL] [Abstract][Full Text] [Related]
24. N-linked α2,6-sialylation of integrin β1 by the sialyltransferase ST6Gal1 promotes cell proliferation and stemness in gestational trophoblastic disease.
Liu J; Dong X; Xie R; Tang Y; Thomas AM; Li S; Liu S; Yu M; Qin H
Placenta; 2024 Apr; 149():18-28. PubMed ID: 38490094
[TBL] [Abstract][Full Text] [Related]
25. Expression of heregulin alpha, erbB2, and erbB3 and their influences on proliferation of gastric epithelial cells.
Noguchi H; Sakamoto C; Wada K; Akamatsu T; Uchida T; Tatsuguchi A; Matsui H; Fukui H; Fujimori T; Kasuga M
Gastroenterology; 1999 Nov; 117(5):1119-27. PubMed ID: 10535875
[TBL] [Abstract][Full Text] [Related]
26. Prognostic value of ERBB family mRNA expression in breast carcinomas.
Bièche I; Onody P; Tozlu S; Driouch K; Vidaud M; Lidereau R
Int J Cancer; 2003 Sep; 106(5):758-65. PubMed ID: 12866037
[TBL] [Abstract][Full Text] [Related]
27. Coordinate suppression of ERBB2 and ERBB3 by enforced expression of micro-RNA miR-125a or miR-125b.
Scott GK; Goga A; Bhaumik D; Berger CE; Sullivan CS; Benz CC
J Biol Chem; 2007 Jan; 282(2):1479-86. PubMed ID: 17110380
[TBL] [Abstract][Full Text] [Related]
28. Homo- and Heteroassociations Drive Activation of ErbB3.
Váradi T; Schneider M; Sevcsik E; Kiesenhofer D; Baumgart F; Batta G; Kovács T; Platzer R; Huppa JB; Szöllősi J; Schütz GJ; Brameshuber M; Nagy P
Biophys J; 2019 Nov; 117(10):1935-1947. PubMed ID: 31653451
[TBL] [Abstract][Full Text] [Related]
29. The HOTAIR/miR-214/ST6GAL1 crosstalk modulates colorectal cancer procession through mediating sialylated c-Met via JAK2/STAT3 cascade.
Liu B; Liu Q; Pan S; Huang Y; Qi Y; Li S; Xiao Y; Jia L
J Exp Clin Cancer Res; 2019 Nov; 38(1):455. PubMed ID: 31694696
[TBL] [Abstract][Full Text] [Related]
30. Prognostic role of the sialyltransferase ST6GAL1 in ovarian cancer.
Wichert B; Milde-Langosch K; Galatenko V; Schmalfeldt B; Oliveira-Ferrer L
Glycobiology; 2018 Nov; 28(11):898-903. PubMed ID: 30016515
[TBL] [Abstract][Full Text] [Related]
31. Heregulin-induced activation of ErbB3 by EGFR tyrosine kinase activity promotes tumor growth and metastasis in melanoma cells.
Ueno Y; Sakurai H; Tsunoda S; Choo MK; Matsuo M; Koizumi K; Saiki I
Int J Cancer; 2008 Jul; 123(2):340-347. PubMed ID: 18398842
[TBL] [Abstract][Full Text] [Related]
32. Chronic morphine treatment attenuates cell growth of human BT474 breast cancer cells by rearrangement of the ErbB signalling network.
Weingaertner IR; Koutnik S; Ammer H
PLoS One; 2013; 8(1):e53510. PubMed ID: 23308242
[TBL] [Abstract][Full Text] [Related]
33. Autocrine activation of ErbB2/ErbB3 receptor complex by NRG-1 in non-small cell lung cancer cell lines.
Gollamudi M; Nethery D; Liu J; Kern JA
Lung Cancer; 2004 Feb; 43(2):135-43. PubMed ID: 14739033
[TBL] [Abstract][Full Text] [Related]
34. ST6Gal1 targets the ectodomain of ErbB2 in a site-specific manner and regulates gastric cancer cell sensitivity to trastuzumab.
Duarte HO; Rodrigues JG; Gomes C; Hensbergen PJ; Ederveen ALH; de Ru AH; Mereiter S; Polónia A; Fernandes E; Ferreira JA; van Veelen PA; Santos LL; Wuhrer M; Gomes J; Reis CA
Oncogene; 2021 May; 40(21):3719-3733. PubMed ID: 33947960
[TBL] [Abstract][Full Text] [Related]
35. The tumor suppressor TSLC1/NECL-2 triggers NK-cell and CD8+ T-cell responses through the cell-surface receptor CRTAM.
Boles KS; Barchet W; Diacovo T; Cella M; Colonna M
Blood; 2005 Aug; 106(3):779-86. PubMed ID: 15811952
[TBL] [Abstract][Full Text] [Related]
36. Changes in heregulin beta1 (HRGbeta1) signaling after inhibition of ErbB-2 expression in a human breast cancer cell line.
Yoo JY; Hamburger AW
Mol Cell Endocrinol; 1998 Mar; 138(1-2):163-71. PubMed ID: 9685225
[TBL] [Abstract][Full Text] [Related]
37. Heregulin-mediated ErbB2-ERK signaling activates hyaluronan synthases leading to CD44-dependent ovarian tumor cell growth and migration.
Bourguignon LY; Gilad E; Peyrollier K
J Biol Chem; 2007 Jul; 282(27):19426-41. PubMed ID: 17493932
[TBL] [Abstract][Full Text] [Related]
38. Mesenchymal stem cells drive paclitaxel resistance in ErbB2/ErbB3-coexpressing breast cancer cells via paracrine of neuregulin 1.
Chen J; Ren Q; Cai Y; Lin T; Zuo W; Wang J; Lin R; Zhu L; Wang P; Dong H; Zhao H; Huang L; Fu Y; Yang S; Tan J; Lan X; Wang S
Biochem Biophys Res Commun; 2018 Jun; 501(1):212-219. PubMed ID: 29715459
[TBL] [Abstract][Full Text] [Related]
39. Epidermal growth factor receptor, c-erbB2 and c-erbB3 receptor interaction, and related cell cycle kinetics of SK-BR-3 and BT474 breast carcinoma cells.
Brockhoff G; Heiss P; Schlegel J; Hofstaedter F; Knuechel R
Cytometry; 2001 Aug; 44(4):338-48. PubMed ID: 11500850
[TBL] [Abstract][Full Text] [Related]
40. Tumor suppressor miR-22 suppresses lung cancer cell progression through post-transcriptional regulation of ErbB3.
Ling B; Wang GX; Long G; Qiu JH; Hu ZL
J Cancer Res Clin Oncol; 2012 Aug; 138(8):1355-61. PubMed ID: 22484852
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
